EctoSeal P2G, our revolutionary powder-to-hydrogel base, is the first natural, biodegradable polymer base created for wound care preparations. Read about the motivation behind its development, as well as clinical applications, from PCCA Clinical Compounding Pharmacist Mark Gonzalez, PharmD.

Multiple studies indicate some patients with COVID-19 infection may develop vertigo. Read how betahistine helped relieve symptoms of vertigo in these post-COVID patients.

Access scientific studies, which include images and videos, conducted by PCCA researchers that evaluated properties and performance of SuspendIt Anhydrous.

PCCA Manager of Science Maria Carvalho discusses presenting 40 Stability Stuies on SuspendIt at International Scientific Conferences.

Two recent compounding case studies describe treatments that helped adults with persistent drooling as well as cats with behavioral issues.

PCCA's Chief Scientific Officer Gus Bassani provides an important and exciting update regarding the work of our Research and Development department over the last 18 months.

Maria Carvalho, Manager of PCCA Science, explains scientific poster presentations and why they are important when it comes to peer-reviewed research of pharmacy compounding

Maria Carvalho discusses the latest versions of the USP (43rd edition) and NF (38th edition), as well as the corresponding USP Compounding Compendium, recognizing the importance of several proprietary PCCA bases

Nat Jones, one of PCCA's Clinical Compounding Pharmacist, discusses the importance of naltrexone and how compounders can use Low-Dose Naltrexone therapy, especially with dermatological health challenges.

Maria Carvalho, Manager of PCCA Science, provides an in-depth look at the science behind Ellage, the first ever anhydrous compounding base developed specifically for vaginal delivery of medications.